95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.85%
Negative revenue growth while FSM stands at 24.05%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.30%
Negative gross profit growth while FSM is at 11.60%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
4.90%
Net income growth under 50% of FSM's 42.23%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.06%
EPS growth under 50% of FSM's 42.86%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
6.06%
Diluted EPS growth under 50% of FSM's 42.86%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.09%
Share change of 0.09% while FSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.31%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
25.60%
Dividend growth of 25.60% while FSM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-8.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-8.64%
Negative FCF growth while FSM is at 215.06%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
50.22%
10Y revenue/share CAGR under 50% of FSM's 159.89%. Michael Burry would suspect a lasting competitive disadvantage.
27.97%
5Y revenue/share CAGR under 50% of FSM's 96.13%. Michael Burry would suspect a significant competitive gap or product weakness.
16.22%
3Y revenue/share CAGR at 75-90% of FSM's 18.90%. Bill Ackman would expect new product strategies to close the gap.
30.94%
10Y OCF/share CAGR under 50% of FSM's 192.90%. Michael Burry would worry about a persistent underperformance in cash creation.
39.76%
Positive OCF/share growth while FSM is negative. John Neff might see a comparative advantage in operational cash viability.
24.07%
Positive 3Y OCF/share CAGR while FSM is negative. John Neff might see a big short-term edge in operational efficiency.
0.37%
Below 50% of FSM's 164.84%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
183.27%
5Y net income/share CAGR similar to FSM's 175.52%. Walter Schloss might see both on parallel mid-term trajectories.
212.45%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
98.34%
10Y equity/share CAGR at 75-90% of FSM's 111.50%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
23.42%
Below 50% of FSM's 92.70%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
14.87%
3Y equity/share CAGR 1.25-1.5x FSM's 11.47%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
139.09%
Dividend/share CAGR of 139.09% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
39.29%
3Y dividend/share CAGR of 39.29% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-3.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
238799900.00%
Inventory growth well above FSM's 178.16%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.20%
Negative asset growth while FSM invests at 6.84%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.85%
Similar to FSM's 2.69%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-59.56%
We’re deleveraging while FSM stands at 15.66%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-55.96%
We cut SG&A while FSM invests at 35.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.